Phase 3 Trial of Nivolumab Shows Survival Advantage in Lung Cancer January 13, 2015December 14, 2022 Matthew Tontonoz
Progress Report from the Cancer Immunology “Dream Team” January 23, 2015December 14, 2022 Alexandra Mulvey